搜尋結果
Penile Implantation
100%
Patient Satisfaction
29%
Penile Prosthesis
22%
Equipment and Supplies
18%
Survival
17%
Liang, Y. C. ,
Chuang, M. T. ,
Ho, F. M. ,
Wu, C. C. ,
Zhuang, S. Y. ,
Lin, S. Y. &
Suk, F. M. ,
2011 ,
於: Evidence-based Complementary and Alternative Medicine. 2011 , 865435.
研究成果: 雜誌貢獻 › 文章 › 同行評審
15,16-dihydrotanshinone I
100%
Salvia miltiorrhiza
65%
Prostate
39%
Carcinoma
31%
Apoptosis
28%
Juan, S. H. ,
Chen, J. J. ,
Chen, C. H. ,
Lin, H. ,
Cheng, C. F. ,
Liu, J. C. ,
Hsieh, M. H. ,
Chen, Y. L. ,
Chao, H. H. ,
Chen, T. H. ,
Chan, P. &
Cheng, T-H. ,
9月 2004 ,
於: American Journal of Physiology - Heart and Circulatory Physiology. 287 ,
3 56-3 ,
p. H1254-H1261 研究成果: 雜誌貢獻 › 文章 › 同行評審
Endothelin-1
100%
Endothelial Cells
68%
Gene Expression
55%
Extracellular Signal-Regulated MAP Kinases
37%
2-(2-(2-chloro-3-(2-(3,3-dimethyl-5-sulfo-1-(4-sulfo-butyl)-3H-indol-2-yl)-vinyl)-cyclohex-2-enylidene)-ethylidene)-3,3-dimethyl-1-(4-sulfo-butyl)-2,3-dihydro-1H-indole-5-carboxylic acid
18%
Tsai, Y. J. ,
Lin, Y. H. ,
Hsu, C-H. &
Yeh, S-D. ,
7月 2013 ,
於: Clinical Imaging. 37 ,
4 ,
p. 791-793 3 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Histoplasmosis
100%
Fluorodeoxyglucose F18
78%
Positron-Emission Tomography
69%
Therapeutics
12%
Calcitriol
100%
Cathepsins
76%
Peptide Hydrolases
71%
Prostatic Neoplasms
67%
Tissue Inhibitor of Metalloproteinase-1
51%
Huang, W. H. ,
Teng, L. C. ,
Yeh, T. K. ,
Chen, Y. J. ,
Lo, W. J. ,
Wu, M. J. ,
Chin, C. S. ,
Tsan, Y. T. ,
Lin, T. C. ,
Chai, J. W. ,
Lin, C. F. ,
Tseng, C. H. ,
Liu, C. W. ,
Wu, C. M. ,
Chen, P. Y. ,
Shi, Z. Y. &
Liu, P. Y. ,
6月 2020 ,
於: Journal of Microbiology, Immunology and Infection. 53 ,
3 ,
p. 481-484 4 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Coronavirus
100%
Taiwan
78%
China
64%
Severe Acute Respiratory Syndrome
51%
Clinical Laboratory Techniques
44%
Chang, C. C. ,
Sue, Y. M. ,
Yang, N. J. ,
Lee, Y-H. &
Juan, S. H. ,
3月 21 2014 ,
於: PLoS One. 9 ,
3 , e92793.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Aryl Hydrocarbon Receptor Agonist
100%
Histone Deacetylase 1
84%
3-Methylcholanthrene
79%
histone deacetylase
77%
cell cycle checkpoints
73%
Chang, C-C. ,
Hsu, Y-H. ,
Chou, H-C. ,
Lee, Y-C. G. &
Juan, S-H. ,
5月 1 2017 ,
於: Journal of Cellular Physiology. 232 ,
5 ,
p. 1020-1029 研究成果: 雜誌貢獻 › 文章 › 同行評審
3-Methylcholanthrene
100%
Aryl Hydrocarbon Receptors
89%
Methylcholanthrene
88%
Nitric Oxide Synthase Type III
79%
Hypertension
45%
Chen, K. Y. ,
Tseng, C. H. ,
Feng, P. H. ,
Sun, W. L. ,
Ho, S. C. ,
Lin, C. W. ,
Van Hiep, N. ,
Luo, C. S. ,
Tseng, Y. H. ,
Chen, T. T. ,
Liu, W. T. ,
Lee, K. Y. &
Wu, S. M. ,
2021 , (接受/付印)
於: Cell Biology and Toxicology. 38 ,
5 ,
p. 865-887 23 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
benzanthrone
100%
Epiregulin
80%
Clonogenic
36%
Epithelial Cells
34%
Environmental Contaminant
31%
Liu, M. ,
Bamodu, O. A. ,
Huang, W. C. ,
Zucha, M. A. ,
Lin, Y. K. ,
Wu, A. T. H. ,
Huang, C. C. ,
Lee, W. H. ,
Yuan, C. C. ,
Hsiao, M. ,
Deng, L. ,
Tzeng, Y. M. &
Yeh, C. T. ,
3月 15 2017 ,
於: Toxicology and Applied Pharmacology. 325 ,
p. 48-60 13 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
4-acetylantroquinonol B
100%
Cisplatin
47%
Phosphatidylinositol 3-Kinases
43%
Autophagy
42%
Hydroxychloroquine
26%
Chang, C. H. C. ,
Chen, K-K. ,
Lin, T. L. ,
Pan, C-C. ,
Chang, Y-H. ,
Huang, J. ,
Kuo, J-Y. ,
Chung, H-J. &
Lin, T. L. ,
4月 1 2015 ,
於: European Urology, Supplements. 14 ,
2 ,
p. e836 研究成果: 雜誌貢獻 › 文章 › 同行評審
Lin, Y. W. ,
Lien, L. M. ,
Yeh, T. S. ,
Wu, H. M. ,
Liu, Y. L. &
Hsieh, R. H. ,
12月 12 2008 ,
於: Biochemical and Biophysical Research Communications. 377 ,
2 ,
p. 351-354 4 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
9-Cis-Retinoic Acid
100%
Alitretinoin
90%
Retinoid X Receptors
82%
Retinoid
79%
Mitochondria
50%
Chen, Y-L. ,
Wu, Y-N. ,
Liao, C-H. ,
Lin, Y-H. ,
Wu, C-C. &
Chiang, H-S. ,
2014 ,
於: Translational Andrology and Urology. 3 ,
0 研究成果: 雜誌貢獻 › 文章 › 同行評審
Chen, Y-L. ,
Wu, Y-N. ,
Liao, C-H. ,
Lin, Y-H. ,
Wu, C-C. &
Chiang, H-S. ,
2014 ,
於: Translational Andrology and Urology. 3 ,
0 研究成果: 雜誌貢獻 › 文章 › 同行評審
Wu, C. C. ,
Chen, J. S. ,
Lu, K. C. ,
Chen, C. C. ,
Lin, S. H. ,
Chu, P. ,
Sytwu, H. K. &
Lin, Y. F. ,
2010 ,
於: Clinica Chimica Acta. 411 ,
9-10 ,
p. 700-704 5 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Diabetic Nephropathies
100%
Proteinuria
90%
Chemokines
88%
Cytokines
58%
Plasma
34%
Lin, Y. Y. ,
Hsu, Y. H. ,
Huang, H. Y. ,
Shann, Y. J. ,
Huang, C. Y. F. ,
Wei, S. C. ,
Chen, C. L. &
Jou, T. S. ,
5月 1 2012 ,
於: Journal of Clinical Investigation. 122 ,
5 ,
p. 1881-1894 14 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Mouse Hnf1a protein
100%
Catenins
59%
Phosphoproteins
55%
T Cell Transcription Factor 1
53%
Carcinogenesis
36%
Liao, C. T. ,
Zheng, C. M. ,
Lin, Y. C. ,
Wu, M. Y. ,
Lin, Y. F. ,
Hsu, Y. H. ,
Hsu, C. C. &
Wu, M. S. ,
1月 13 2021 ,
於: Scientific Reports. 11 ,
1 , 1171.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Peritoneal Dialysis
100%
Phosphorus
97%
Peritonitis
94%
Parathyroid Hormone
92%
Calcium
63%
Lin, Y. C. ,
Lin, Y. C. ,
Chen, T-W. ,
Yang, W. C. &
Lin, C. C. ,
2月 2012 ,
於: Journal of the Chinese Medical Association. 75 ,
2 ,
p. 54-59 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Peritoneal Dialysis
100%
Longitudinal Studies
76%
Thyroid Gland
76%
Mortality
46%
C-Reactive Protein
17%
Kao, W-T. ,
Shen, C-H. ,
Kiu, K-T. ,
Chen, H-A. ,
Wu, C-C. &
Wang, Y-H. ,
8月 1 2015 ,
於: Cancer Research. 75 ,
15 Supplement 研究成果: 雜誌貢獻 › 文章 › 同行評審
Spontaneous Coronary Artery Dissection
100%
Stents
54%
Coronary Angiography
37%
Optical Coherence Tomography
25%
Hematoma
23%
Lin, L. Y. ,
Peng, R. Y. ,
Peng, C. C. ,
Wang, H. E. ,
Chuang, C. M. ,
Yu, T. H. ,
Chen, K. C. &
Chiu, W. T. ,
2008 ,
於: Food and Bioprocess Technology. 1 ,
3 ,
p. 234-245 12 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Sorghum
100%
nanogold
85%
Acetic acid
77%
Acetic Acid
64%
Acceleration
58%
Wang, C. C. ,
Sue, Y. M. ,
Yang, C. H. &
Chen, C. K. ,
5月 2006 ,
於: Journal of the American Academy of Dermatology. 54 ,
5 ,
p. 804-810 7 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Lentigo
100%
Melanosis
90%
Solid-State Lasers
75%
Lasers
54%
Light
47%
Chang, K. Y. ,
Chen, Y. C. ,
Yeh, S. C. ,
Kao, C. C. ,
Cheng, C. Y. ,
Kang, Y. N. &
Huang, C. W. ,
3月 1 2022 ,
於: Nutrients. 14 ,
6 , 1250.
研究成果: 雜誌貢獻 › 文章 › 同行評審
omega-6 fatty acids
100%
high density lipoprotein
98%
low density lipoprotein
95%
dialysis
87%
LDL Lipoproteins
87%
Chen, K. C. ,
Peng, C. C. ,
Chiu, W. T. ,
Cheng, Y. T. ,
Huang, G. T. ,
Hsieh, C. L. &
Peng, R. Y. ,
2月 2010 ,
於: Nutrition and Cancer. 62 ,
2 ,
p. 260-270 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Psidium
100%
Prostatic Neoplasms
48%
Signal Transduction
48%
Prostate-Specific Antigen
42%
Metribolone
32%
Peng, C. C. ,
Liu, J. H. ,
Chang, C. H. ,
Chung, J. Y. ,
Chen, K. C. ,
Chou, K. Y. &
Peng, R. Y. ,
2013 ,
於: Evidence-based Complementary and Alternative Medicine. 2013 , 408734.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Ginkgo biloba extract
100%
Ginkgo biloba
99%
Exercise Therapy
85%
Prostatic Hyperplasia
67%
Hyperplasia
62%
Lin, H. ,
Li, H. F. ,
Chen, H-H. ,
Lai, P. F. ,
Juan, S-H. ,
Chen, J. J. &
Cheng, C. F. ,
2014 ,
於: Molecular Pharmacology. 85 ,
5 ,
p. 682-691 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Activating Transcription Factor 3
100%
Beclin-1
80%
Autophagy
60%
Heart Failure
46%
Pressure
40%
Lin, H. ,
Sue, Y. M. ,
Chou, Y. ,
Cheng, C. F. ,
Chang, C. C. ,
Li, H. F. ,
Chen, C. C. &
Juan, S. H. ,
12月 2010 ,
於: British Journal of Pharmacology. 161 ,
7 ,
p. 1661-1676 16 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Carboplatin
100%
Oxidative Stress
65%
T-Lymphocytes
55%
Apoptosis
54%
Kidney
47%
Lu, S. H. ,
Hsu, W. L. ,
Chen, T. H. &
Chou, T. C. ,
12月 1 2015 ,
於: International Immunopharmacology. 29 ,
2 ,
p. 770-778 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
magnolol
100%
Porphyromonas gingivalis
74%
Heme Oxygenase-1
60%
Lipopolysaccharides
51%
Anti-Inflammatory Agents
44%
Lin, L. Y. ,
Peng, C-C. ,
Wang, H. E. ,
Liu, Y. W. ,
Shen, K. H. ,
Chen, K-C. &
Peng, R. Y. ,
11月 16 2016 ,
於: Journal of Essential Oil-Bearing Plants. 19 ,
8 ,
p. 1957-1983 27 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
perillaldehyde
100%
Perilla frutescens
88%
linalool
63%
Volatile Oils
59%
Linalool
49%
Huang, B. T. ,
Lai, W. Y. ,
Chang, Y. C. ,
Wang, J. W. ,
Yeh, S. D. ,
Lin, E. P. Y. &
Yang, P. C. ,
9月 15 2017 ,
於: Molecular Therapy - Nucleic Acids. 8 ,
p. 520-528 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Nucleotide Aptamers
100%
CTLA-4 Antigen
95%
Developmental
82%
Pipeline
79%
Dissociation Constant
63%
Lin, Y. C. ,
Chen, Y. C. ,
Chen, T. H. ,
Chen, H. H. &
Tsai, W. J. ,
8月 2011 ,
於: Journal of Experimental and Clinical Medicine(Taiwan). 3 ,
4 ,
p. 184-186 3 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
pien tze huang
100%
Acute Kidney Injury
46%
Panax notoginseng
10%
Hypergravity
10%
Azotemia
9%
Liu, C. H. ,
Chiu, H. C. ,
Sung, H. L. ,
Yeh, J. Y. ,
Wu, K. C. W. &
Liu, S. H. ,
10月 2019 ,
於: Regulatory Toxicology and Pharmacology. 107 , 104426.
研究成果: 雜誌貢獻 › 文章 › 同行評審
MIL-101
100%
Acute Toxicity Oral
75%
Nanoparticles
40%
Dose
34%
Metal-Organic Frameworks
23%
Duong, V. T. ,
Tseng, I. H. ,
Wong, T. C. ,
Chen, H. H. ,
Chen, T. H. ,
Hsu, Y. H. ,
Peng, S. J. ,
Kuo, K. L. ,
Liu, H. C. ,
Lin, E. T. ,
Feng, Y. W. &
Yang, S. H. ,
6月 21 2019 ,
於: Nutrients. 11 ,
6 , 1407.
研究成果: 雜誌貢獻 › 文章 › 同行評審
healthy eating habits
100%
hemodialysis
89%
Healthy Diet
77%
Renal Dialysis
59%
Mortality
34%
Cheng, C. F. ,
Ku, H. C. ,
Cheng, J. J. ,
Chao, S. W. ,
Li, H. F. ,
Lai, P. F. ,
Chang, C. C. ,
Don, M. J. ,
Chen, H. H. &
Lin, H. ,
12月 1 2019 ,
於: Communications Biology. 2 ,
1 , 389.
研究成果: 雜誌貢獻 › 文章 › 同行評審
adipocytes
100%
obesity
97%
Adipocytes
88%
Inducer
71%
Obesity
64%
Lin, H. ,
Lian, W. S. ,
Chen, H. H. ,
Lai, P. F. &
Cheng, C. F. ,
8月 2013 ,
於: Molecular Pharmacology. 84 ,
2 ,
p. 275-285 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Peroxisome Proliferator-Activated Receptors
100%
Iron Overload
99%
Adiponectin
89%
Cardiomyopathies
80%
Iron
43%
Lin, Y. F. ,
Deng, M. C. ,
Tseng, L. P. ,
Jiang, P. R. ,
Jan, T. R. ,
Hsieh, F. I. &
Liu, D. Z. ,
2011 ,
於: Biomedical Materials. 6 ,
1 , 015011.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Liposomes
100%
Intranasal
98%
Nitric oxide
83%
Adjuvant
75%
Chickens
59%
Wu, V. C. ,
Hu, Y. H. ,
Wu, C. H. ,
Kao, C. C. ,
Wang, C. Y. ,
Yang, W. S. ,
Lee, H. H. ,
Chang, Y. S. ,
Lin, Y. H. ,
Wang, S. M. ,
Chen, L. &
Wu, K. D. ,
10月 1 2014 ,
於: Journal of Clinical Epidemiology. 67 ,
10 ,
p. 1139-1149 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Mineralocorticoid Receptor Antagonists
100%
Hyperaldosteronism
94%
Taiwan
73%
Prescriptions
62%
National Health Programs
15%
Chen, K-H. ,
Liu, H. E. ,
Chen, T-H. ,
Su, H. C. ,
Kuo, K. N. &
Chen, C. C. ,
9月 16 2017 ,
於: Cochrane Database of Systematic Reviews. 9 研究成果: 雜誌貢獻 › 文章 › 同行評審
Translational Medical Research
100%
Accidental Falls
70%
Guidelines
26%
Health
13%
Wounds and Injuries
13%
Pan, S. C. ,
Hsu, W. T. ,
Lee, W. S. ,
Wang, N. C. ,
Chen, T. J. ,
Liu, M. C. ,
Pai, H. C. ,
Hsu, Y. S. ,
Chang, M. &
Hsieh, S. M. ,
1月 29 2020 ,
於: Vaccine. 38 ,
5 ,
p. 1048-1056 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
influenza vaccines
100%
inactivated vaccines
88%
Inactivated Vaccines
83%
immunogenicity
79%
Influenza Vaccines
76%
Chang, P. C. ,
Chen, T. H. ,
Chang, C-J. ,
Hou, C-C. ,
Chan, P. &
Lee, H. M. ,
5月 2004 ,
於: Kidney International. 65 ,
5 ,
p. 1664-1675 12 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Advanced Glycation End Products
100%
Mesangial Cells
87%
Nitric Oxide Synthase Type II
87%
p38 Mitogen-Activated Protein Kinases
85%
Nitrites
56%
Chiang, H-S. ,
Lin, Y. H. ,
Wu, Y. N. ,
Wu, C. C. ,
Liu, M. C. &
Lin, C. M. ,
8月 2013 ,
於: Urology. 82 ,
2 ,
p. 345-351 7 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Congenital bilateral aplasia of vas deferens
100%
Vas Deferens
77%
Seminal Vesicles
73%
Magnetic Resonance Imaging
40%
Ultrasonography
23%
Lo, P-H. ,
Chang, C-C. ,
Yeh, C-C. ,
Sung, L-C. ,
Cherng, Y-G. ,
Chen, T-L. &
Liao, C-C. ,
2021 ,
於: Journal of Clinical Medicine. 10 ,
7 ,
p. 1501 1 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Cherng, Y. G. ,
Chang, C. C. ,
Yeh, C. C. ,
Hsu, Y. H. ,
Chen, T. L. &
Liao, C. C. ,
1月 1 2019 ,
於: Clinical Epidemiology. 11 ,
p. 707-719 13 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Propensity Score
100%
Chronic Renal Insufficiency
85%
Odds Ratio
37%
Kidney Diseases
36%
Confidence Intervals
34%
Chen, M. X. ,
Su, H. H. ,
Shiao, C. Y. ,
Chang, Y. T. ,
Chang, M. C. ,
Kao, C. C. ,
Wang, S. Y. ,
Shih, H. C. &
Tsai, I. L. ,
11月 1 2021 ,
於: International journal of molecular sciences. 22 ,
21 , 11527.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Glycosylation
100%
Autoimmune Pancreatitis
81%
Isotopes
69%
purification
64%
Purification
64%
Yang, H. Y. ,
Huang, S. M. ,
Lu, K. C. ,
Wu, C. C. ,
Kang, C. Y. ,
Lin, Y. F. ,
Lin, C. ,
Lin, F. H. ,
Kao, S. Y. &
Su, S. L. ,
5月 22 2014 ,
於: American Journal of Nephrology. 40 ,
2 ,
p. 131-139 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Toll-Like Receptor 3
100%
Genetic Promoter Regions
67%
Chronic Kidney Failure
61%
Alleles
13%
Haplotypes
11%
Wu, M. Y. ,
Fu, T. S. ,
Chang, C. H. ,
Hsu, H. H. ,
Chang, M. Y. ,
Tian, Y. C. ,
Hung, C. C. ,
Fang, J. T. ,
Chen, L. H. &
Chen, Y. C. ,
7月 2011 ,
於: Renal Failure. 33 ,
6 ,
p. 582-586 5 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Epidural Abscess
100%
Chronic Kidney Failure
61%
Surgical Decompression
5%
Blood Sedimentation
4%
Hematocrit
4%
Huang, W. J. ,
Tang, Y. A. ,
Chen, M. Y. ,
Wang, Y. J. ,
Hu, F. H. ,
Wang, T. W. ,
Chao, S. W. ,
Chiu, H. W. ,
Yeh, Y. L. ,
Chang, H. Y. ,
Juan, H. F. ,
Lin, P. &
Wang, Y. C. ,
4月 28 2014 ,
於: Cancer Letters. 346 ,
1 ,
p. 84-93 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Histone Deacetylase Inhibitors
100%
Cisplatin
77%
Non-Small Cell Lung Carcinoma
76%
Lung Neoplasms
33%
Neoplasms
27%
Zheng, J. Q. ,
Lin, C. H. ,
Lee, H. H. ,
Chang, W. M. ,
Li, L. J. ,
Su, C. Y. ,
Lee, K. Y. ,
Chiu, H. W. &
Lin, Y. F. ,
2022 , (接受/付印)
於: Cancer Science. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Adenocarcinoma of Lung
100%
Melanoma
77%
Up-Regulation
67%
Ligands
66%
Apoptosis
57%